1.
Clin Case Rep
; 9(9): e04805, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34567553
RESUMO
Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute-phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a "platelet dilemma" in therapeutic decision-making.